Patent ID: 7601369
Filing Date: 2009-10-13
Classification: A23L,A23V,A61K,A61P

Abstract:
1. A method for enhancing epinephrine and norepinephrine neurotransmitter activity, comprising orally administering to a subject in need thereof a composition comprising: at least one first component selected from the group consisting of tryptophan and 5-hydroxytryptophan in the range of from about 1 mg to about 100 mg; at least one second component selected from the group consisting of glutamine, predigested protein, at least one third component selected from the group consisting of cocoa, caffeine, and theobromine in the range of from about 1 mg to about 200 mg; at least one fourth component selected from the group consisting of neuroexcitatory amino acids, glutamate, glutamic acid, and glutamine in the range of from about 1 mg to about 200 mg; and hawthorn berry as a fifth component in the range of from about 1 mg to about 200 mg, wherein the proportions of the five or more components are determined by testing said subject using a physiologic test selected from the group consisting of heart rate, 24 hour Electrocardiogram analysis, blood pressure, body temperature, skin temperature, and a neurotransmitter blood test.